Comparative performance of PD ‐ L1 scoring by pathologists and AI algorithms
Histopathology · 2025-07 · 87 (1) · 90-100
DOI: 10.1111/his.15432 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Histopathology, online erschienen am 17.02.2025. Verfasst von Markus Plass und 11 weiteren Autor:innen. Beteiligte Einrichtung: Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Algorithms, B7-H1 Antigen. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund, European Commission.
Abstract (Originalsprache)
Aim This study evaluates the comparative effectiveness of pathologists versus artificial intelligence (AI) algorithms in scoring PD‐L1 expression in non‐small cell lung carcinoma (NSCLC). Immune‐checkpoint inhibitors have revolutionized NSCLC treatment, with PD‐L1 expression, measured as the tumour proportion score (TPS), serving as a critical predictive biomarker for therapeutic response. Methods and Results In our analysis, 51 SP263‐stained NSCLC cases were scored by six pathologists using light microscopy and whole‐slide images (WSI), alongside evaluations by two commercially available software tools: uPath software (Roche) and the PD‐L1 Lung Cancer TME application (Visiopharm). The study examined intra‐ and interobserver agreement among pathologists at TPS cutoffs of 1% and 50%, revealing moderate interobserver agreement (Fleiss' kappa 0.558) for TPS
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
- Department of Pathology, British Columbia Cancer Agency, Vancouver, BC, Canada.
- Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
- University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
- Cytology and Pathology Laboratory, University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia.
- Department of Pathology Informatics, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
ORCID-Profile: Markus Plass, Gheorghe-Emilian Olteanu, Sanja Dacic, Izidor Kern, Martin Zacharias, Helmut Popper, Junya Fukuoka, Sosuke Ishijima, Michaela Kargl, Lipika Kalson, Luka Brcic
Förderung
- Austrian Science Fund
- European Commission
Zitieren
APA
Plass, M., Olteanu, G. E., Dacic, S., Kern, I., Zacharias, M., Popper, H., Fukuoka, J., Ishijima, S., Kargl, M., Murauer, C., Kalson, L., & Brcic, L. (2025). Comparative performance of PD ‐ L1 scoring by pathologists and AI algorithms. Histopathology, 87(1), 90-100. https://doi.org/10.1111/his.15432
Vancouver
Plass M, Olteanu GE, Dacic S, Kern I, Zacharias M, Popper H, et al. Comparative performance of PD ‐ L1 scoring by pathologists and AI algorithms. Histopathology. 2025;87(1):90-100. doi:10.1111/his.15432
BibTeX
@article{Plass2025,
author = {Plass, Markus and Olteanu, Gheorghe-Emilian and Dacic, Sanja and Kern, Izidor and Zacharias, Martin and Popper, Helmut and Fukuoka, Junya and Ishijima, Sosuke and Kargl, Michaela and Murauer, Christoph and Kalson, Lipika and Brcic, Luka},
title = {Comparative performance of PD ‐ L1 scoring by pathologists and AI algorithms},
journal = {Histopathology},
year = {2025},
volume = {87},
number = {1},
pages = {90--100},
doi = {10.1111/his.15432}
}
EUVIMED